menu
    • menu

    Company profile for CervoMed

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CervoMed is a clinical-stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as EIP Pharma Inc. EIP Pharma Inc is now a wholly-owned subsidiary of CervoMed. The company's lead product candidate, neflamapimod, is currently in clinical development as a disease-modi...
    CervoMed is a clinical-stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as EIP Pharma Inc. EIP Pharma Inc is now a wholly-owned subsidiary of CervoMed. The company's lead product candidate, neflamapimod, is currently in clinical development as a disease-modifying treatment for neurodegenerative diseases, such as dementia with Lewy Bodies and early Alzheimer’s disease. In addition, pre-clinical data supports the potential role of neflamapimod in recovery after stroke.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CervoMedUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Park Plaza, Suite 424 Boston, MA 02116
    Telephone
    Telephone
    +1 6177444400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cervomed.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cervomed/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Cervo_Med

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CervoMed Presents Neflamapimod Data At AD/PD 2026 Conference
    CervoMed Presents Neflamapimod Data At AD/PD 2026 Conference

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258892/0/en/CervoMed-Announces-New-Data-at-the-AD-PD-2026-Scientific-Conference-that-Reinforce-Neflamapimod-s-Positive-Effects-in-Dementia-with-Lewy-Bodies-DLB-in-Patients-without-Alzheimer-s-.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    CervoMed Reports 2025 Financial Results & Corporate Updates
    CervoMed Reports 2025 Financial Results & Corporate Updates

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257039/0/en/CervoMed-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    CervoMed To Present At AD/PD 2026 Conference
    CervoMed To Present At AD/PD 2026 Conference

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254471/0/en/CervoMed-Announces-Presentations-at-Upcoming-AD-PD-2026-Scientific-Conference.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    CervoMed To Participate In Upcoming Investor Conferences
    CervoMed To Participate In Upcoming Investor Conferences

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250044/0/en/CervoMed-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Cervomed Reveals Neflamapimod Slows Dementia Progression At CTAD
    Cervomed Reveals Neflamapimod Slows Dementia Progression At CTAD

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3200383/0/en/CervoMed-Announces-Late-Breaking-Data-at-the-18th-CTAD-Conference-Demonstrating-Neflamapimod-Significantly-Slows-Clinical-Progression-in-Dementia-with-Lewy-Bodies.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Cervomed Shows Neflamapimod Improves Neuroinflammation In (DLB)
    Cervomed Shows Neflamapimod Improves Neuroinflammation In (DLB)

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197738/0/en/CervoMed-Presents-New-Plasma-Biomarker-Data-That-Indicates-Neflamapimod-Broadly-Improves-Neuroinflammation-and-Neurodegeneration-in-Dementia-with-Lewy-Bodies-DLB.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search